Cargando…

Attenuated mismatch negativity in patients with first-episode antipsychotic-naive schizophrenia using a source-resolved method

BACKGROUND: Mismatch negativity (MMN) is a measure of pre-attentive auditory information processing related to change detection. Traditional scalp-level EEG methods consistently find attenuated MMN in patients with chronic but not first-episode schizophrenia. In the current paper, we use a source-re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Randau, M., Oranje, B., Miyakoshi, M., Makeig, S., Fagerlund, B., Glenthøj, B., Bak, N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6444292/ https://www.ncbi.nlm.nih.gov/pubmed/30927608 http://dx.doi.org/10.1016/j.nicl.2019.101760

Ejemplares similares

Alterations of Intrinsic Connectivity Networks in Antipsychotic-Naïve First-Episode Schizophrenia
por: Anhøj, Simon, et al.
Publicado: (2018)

Two subgroups of antipsychotic-naive, first-episode schizophrenia patients identified with a Gaussian mixture model on cognition and electrophysiology
por: Bak, N, et al.
Publicado: (2017)

Effects of Blocking D2/D3 Receptors on Mismatch Negativity and P3a Amplitude of Initially Antipsychotic Naïve, First Episode Schizophrenia Patients
por: Düring, Signe, et al.
Publicado: (2015)

Accuracy of diagnostic classification algorithms using cognitive-, electrophysiological-, and neuroanatomical data in antipsychotic-naïve schizophrenia patients
por: Ebdrup, Bjørn H., et al.
Publicado: (2019)

Macroscale EEG characteristics in antipsychotic-naïve patients with first-episode psychosis and healthy controls
por: Dominicus, L. S., et al.
Publicado: (2023)

Volume alteration of hippocampal subfields in first-episode antipsychotic-naïve schizophrenia patients before and after acute antipsychotic treatment
por: Li, Wenbin, et al.
Publicado: (2018)

Striatal D(2/3) Binding Potential Values in Drug-Naïve First-Episode Schizophrenia Patients Correlate With Treatment Outcome
por: Wulff, Sanne, et al.
Publicado: (2015)

A machine-learning framework for robust and reliable prediction of short- and long-term treatment response in initially antipsychotic-naïve schizophrenia patients based on multimodal neuropsychiatric data
por: Ambrosen, Karen S., et al.
Publicado: (2020)

F176. CLINICAL CORRELATES OF CORTICAL STRUCTURE IN ANTIPSYCHOTIC-NAïVE SCHIZOPHRENIA PATIENTS BEFORE AND AFTER SIX-WEEK TREATMENT WITH A DOPAMINE D2/3 RECEPTOR ANTAGONIST
por: Jessen, Kasper, et al.
Publicado: (2018)

S12. A MACHINE LEARNING FRAMEWORK FOR ROBUST AND RELIABLE PREDICTION OF SHORT- AND LONG-TERM CLINICAL RESPONSE IN INITIALLY ANTIPSYCHOTIC-NAïVE SCHIZOPHRENIA PATIENTS BASED ON MULTIMODAL NEUROPSYCHIATRIC DATA
por: Ambrosen, Karen S, et al.
Publicado: (2020)

S150. DOPAMINE SYNTHESIS CAPACITY IN ANTIPSYCHOTIC NAïVE FIRST EPISODE PSYCHOTIC PATIENTS
por: Sigvard, Anne, et al.
Publicado: (2018)

O6.3. ASSOCIATIONS BETWEEN COGNITIVE FUNCTION AND CORTICAL LEVELS OF GLUTAMATE AND GABA IN ANTIPSYCHOTIC-NAïVE PATIENTS WITH SCHIZOPHRENIA OR PSYCHOSIS
por: Bojesen, Kirsten, et al.
Publicado: (2020)

Structural and Functional Default Mode Network Connectivity and Antipsychotic Treatment Response in Medication-Naïve First Episode Psychosis Patients
por: Maximo, Jose O, et al.
Publicado: (2021)

Cortical substrates and functional correlates of auditory deviance processing deficits in schizophrenia
por: Rissling, Anthony J., et al.
Publicado: (2014)

Striatal Volume Increase After Six Weeks of Selective Dopamine D(2/3) Receptor Blockade in First-Episode, Antipsychotic-Naïve Schizophrenia Patients
por: Andersen, Helle G., et al.
Publicado: (2020)

Corpus callosum volumes in the 5 years following the first-episode of schizophrenia: Effects of antipsychotics, chronicity and maturation
por: de Moura, Mariana T.M., et al.
Publicado: (2018)

Concurrent functional magnetic resonance imaging and electroencephalography assessment of sensory gating in schizophrenia
por: Bak, Nikolaj, et al.
Publicado: (2013)

Associations Between Cognitive Function and Levels of Glutamatergic Metabolites and Gamma-Aminobutyric Acid in Antipsychotic-Naïve Patients With Schizophrenia or Psychosis
por: Bojesen, Kirsten Borup, et al.
Publicado: (2021)

Impaired interactions among white‐matter functional networks in antipsychotic‐naive first‐episode schizophrenia
por: Fan, Yun‐Shuang, et al.
Publicado: (2019)

Magnetization transfer imaging alterations and its diagnostic value in antipsychotic-naïve first-episode schizophrenia
por: Lei, Du, et al.
Publicado: (2022)

Gene Expressions Preferentially Influence Cortical Thickness of Human Connectome Project Atlas Parcellated Regions in First-Episode Antipsychotic-Naïve Psychoses
por: McGuigan, Bridget N, et al.
Publicado: (2023)

The effect of atypical antipsychotics on brain N-acetylaspartate levels in antipsychotic-naïve first-episode patients with schizophrenia: a preliminary study
por: Grošić, Vladimir, et al.
Publicado: (2014)

Probiotics Plus Dietary Fiber Supplements Attenuate Olanzapine-Induced Weight Gain in Drug-Naïve First-Episode Schizophrenia Patients: Two Randomized Clinical Trials
por: Huang, Jing, et al.
Publicado: (2022)

F21. ELECTROPHYSIOLOGICAL PARAMETERS OF SELECTIVE ATTENTION IN ADOLESCENTS WITH A FIRST EPISODE OF PSYCHOSIS: A COMPARISON WITH ADHD
por: Selten, Iris, et al.
Publicado: (2018)

Neuroanatomical correlates of psychopathology in antipsychotic-naïve schizophrenia
por: Venkatasubramanian, Ganesan
Publicado: (2010)

Thalamic Shape Abnormalities in Antipsychotic Naïve Schizophrenia
por: Danivas, Vijay, et al.
Publicado: (2013)

Entorhinal Cortex Volume in Antipsychotic-naïve Schizophrenia
por: Jose, Sam P., et al.
Publicado: (2012)

Pitch and Duration Mismatch Negativity are Associated With Distinct Auditory Cortex and Inferior Frontal Cortex Volumes in the First-Episode Schizophrenia Spectrum
por: Curtis, Mark T, et al.
Publicado: (2021)

Brain Connectivity Studies in Schizophrenia: Unravelling the Effects of Antipsychotics
por: Nejad, Ayna B, et al.
Publicado: (2012)

Outpatient Antipsychotic Treatment and Inpatient Costs of Schizophrenia
por: Marcus, Steven C., et al.
Publicado: (2008)

M148. NORMALIZATION IN REWARD PROCESSING DURING INITIAL TREATMENT MAY PREDICT LONG-TERM CLINICAL OUTCOME IN ANTIPSYCHOTIC NAïVE SCHIZOPHRENIA PATIENTS
por: Nielsen, Mette, et al.
Publicado: (2020)

S158. REWARD ALTERATIONS IN ANTIPSYCHOTIC NAïVE FIRST-EPISODE-PSYCHOSIS PATIENTS BEFORE AND AFTER TREATMENT WITH A PARTIAL DOPAMINE AGONIST
por: Tangmose, Karen, et al.
Publicado: (2018)

Lower Vitamin C Levels Are Associated With Less Improvement in Negative Symptoms in Initially Antipsychotic-Naïve Patients With First-Episode Psychosis
por: Myken, Anders N, et al.
Publicado: (2022)

F236. CLONIDINE NORMALIZES MMN IN SCHIZOPHRENIA PATIENTS ON STABLE MEDICATION
por: Kruiper, Caitlyn, et al.
Publicado: (2018)

Association of telomere length and mitochondrial DNA copy number with risperidone treatment response in first-episode antipsychotic-naïve schizophrenia
por: Li, Zongchang, et al.
Publicado: (2015)

Reduced Levels and Disrupted Biosynthesis Pathways of Plasma Free Fatty Acids in First-Episode Antipsychotic-Naïve Schizophrenia Patients
por: Zhou, Xiang, et al.
Publicado: (2020)

Multidimensional predictors of negative symptoms in antipsychotic-naive first-episode psychosis
por: Toll, Alba, et al.
Publicado: (2022)

Primary Nonadherence to Antipsychotic Treatment Among Persons with Schizophrenia
por: Lieslehto, Johannes, et al.
Publicado: (2022)

Schneider’s first-rank symptoms as predictors of remission in antipsychotic-naive first-episode psychosis
por: Malinowski, Fernando R., et al.
Publicado: (2019)

Long-Acting Injectable Antipsychotics in First-Episode Schizophrenia
por: Parellada, Eduard, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_2lbh4j3ugi175thjh9vgrahs24